DAY 3 - Monday, October 24
|
|
REFRACTIVE SURGERY
Study: New LASIK benchmark
Orlando—An ongoing prospective, multicenter study is designed to establish the experience of contact lens wearers as a new benchmark for judging LASIK outcomes, said Francis Price Jr., MD. » MORE
|
|
Shield promising for PRK
Orlando—Postoperative placement of a novel ocular shield is showing benefit for accelerating the rate of re-epithelialization and visual recovery after surface ablation, said Daniel S. Durrie, MD. » MORE
|
|
CORNEA
Contact lenses alter landscape
Orlando—A review of the current landscape and look to the future identifies multiple reasons why contact lenses are an important component in a comprehensive ophthalmology practice, said Michael H. Goldstein, MD, MBA. » MORE |
|
CATARACT
Data: ELP after capsulotomy
Orlando—Using a femtosecond laser to create the capsulotomy provides an incremental but statistically significant improvement in accuracy of refractive outcomes after cataract surgery, said Warren E. Hill, MD. » MORE
|
|
RETINA
Pros, cons of steroid use
Orlando—No clear-cut guidelines currently exist for the use of steroids in patients who develop endophthalmitis, said Brandon Bushbee, MD. » MORE
|
|
Safety: Intravitreal injections
Orlando—Intravitreal injections are the most common procedure performed by retina specialists to treat age-related macular edema, retinal vein occlusion, and diabetic macular edema, noted William Mieler, MD. » MORE
|
|
NEURO-OPHTHALMOLOGY
Radiosurgery benefits tumors
Orlando—Fractionated stereotactic radiosurgery (SRS) (CyberKnife Robotic Radiosurgery System, Accuray Inc.) seems to be beneficial for managing difficult perioptic lesions, according to Andrew Harrison, MD, who reported the results of a retrospective analysis. » MORE |
|
Drug ineffective for NAION
Orlando—Intravitreal bevacizumab (Avastin, Genentech) was not beneficial for patients with non-arteritic ischemic optic neuropathy (NAION), according to Daniel Rootman, MSc, MD, who presented the 6-month results of a prospective trial. » MORE |
|
FROM THE SHOW FLOOR
Iridex adds laser module
Orlando—Iridex Corp. announced that it has expanded its product offering by introducing an optional MicroPulse module in the company’s IQ532 (green) laser system and now provides a complete portfolio of infrared, yellow, and green laser systems which can deliver laser treatments. » MORE |
|
WebMD, B + L collaborate
Orlando—WebMD Health Corp. and Bausch + Lomb introduced new online resources for both consumers and eye-care professionals. The resources are designed to educate consumers about the link between eye health and other health conditions and to encourage a dialogue between doctors and patients. » MORE |
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
|
|
|
Exhibit Hall Hours
Saturday, October 22
9 a.m. – 5 p.m.
Sunday, October 23
9 a.m. – 5 p.m.
Monday, October 24
9 a.m. – 5 p.m.
Tuesday, October 25
9 a.m. – 3 p.m.
We welcome your feedback!
Please send your comments to:
Mark Dlugoss
Editor-in-Chief
Advanstar Eye Health Group
[email protected] |
|
